Capital Fund Management »

Akero Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $539k 21k 25.26
2023-03-31 $583k 15k 38.26

More positions owned by Capital Fund Management

NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
JPMorgan Chase & Co. Call Option (JPM)
Microsoft Corporation Call Option (MSFT)
Bank of America Corporation (BAC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Paypal Holdings (PYPL)
Tesla Motors Call Option (TSLA)
Super Micro Computer Call Option (SMCI)
Citigroup Com New (C)

View all positions for Capital Fund Management

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics